乌头碱的代谢产物去氧乌头碱的生物转化及其电喷雾串联质谱

采用人肠内细菌和乌头碱体外温孵的方法, 探讨去氧乌头碱在人肠内的生物转化. 利用离子阱和傅里叶变换离子回旋共振质谱直接分析去氧乌头碱的转化产物. 乌头类生物碱及其代谢产物在正离子电喷雾质谱条件下形成质子化分子([M+H]+), 通过多级串联质谱进行结构表征. 去氧乌头碱可被人肠内细菌转化, 通过脱酰基、脱甲基脱羟基以及酯化反应产生新型的单酯型、双酯型和脂类生物碱等10余种代谢产物. 双酯型的去氧乌头碱的毒性较高, 当它被肠内细菌转化为单酯型和脂类生物碱时会使其毒性降低.     

高效液相色谱-电喷雾串联四极杆质谱法研究人尿中毛果芸香碱代谢产物

本文采用高效液相色谱-电喷雾串联四极杆质谱法对人口服毛果芸香碱后的尿样的代谢产物进行了研究.     

高效液相色谱-质谱法测定乌头碱在急性中毒大鼠体内的分布

为配合乌头类药材合理应用,本文建立了高效液相色谱-质谱联用(HPLC—MS)测定组织样品中乌头碱的方法,并对急性中毒大鼠体内的乌头碱分布进行了测定。     

液相色谱-串联质谱法筛查原多甲藻酸毒素及其代谢产物

建立了原多甲藻酸毒素(azaspiracids,AZAs)及其代谢产物的液相色谱-串联质谱检测方法,考察了目标代谢产物检测方法和非目标多离子检测方法,将二级质谱图与标准品谱库进行比对,从而获得高精准定性。通过对产毒藻、蓄积代谢实验样品和实际阳性样品综合分析,共检出11种AZAs,其中包括AZA-2,3,6,11,12,16,17,28和36,以及AZAs的谷胱甘肽结合型代谢产物。结果发现,目标代谢产物检测法可无偏差地筛出常规代谢物,而且对低浓度代谢产物表现出更佳的响应。本方法重现性好,数据分析简单,对操作人员的专业要求不高,更适合AZAs的监控要求。     

液相色谱-串联质谱法同时测定血浆中白藜芦醇苷及其代谢产物

建立同时测定大鼠血浆中白藜芦醇苷及其代谢产物白藜芦醇的液相色谱-串联质谱方法。以Lichro-spher C18色谱柱为分析柱,乙腈-水为流动相,采用电喷雾离子源(ESI),以多反应监测(MRM)模式检测,内标法定量,用于定量分析的离子反应分别为m/z389/227(白藜芦醇苷)和m/z227/143(白藜芦醇)。血浆中的白藜芦醇苷及白藜芦醇用乙酸乙酯提取,N2吹干乙酸乙酯,残留物用甲醇溶解,注入LC/MS/MS系统进行检测。在选定的样品预处理、色谱及质谱条件下,白藜芦醇苷、白藜芦醇及内标物能够达到基线分离而且离子化效果好。用LC/MS/MS法检测大鼠血浆中的白藜芦醇苷及其代谢产物白藜芦醇,线性范围0.4~200μg/L,日内、日间精密度(RSD)均小于15%;检测血浆低、中、高3个浓度(1、20、100μg/L)白藜芦醇苷的回收率分别为106.2%、97.8%和91.6%;检测血浆低、中、高3个浓度(1、20、100μg/L)白藜芦醇的回收率分别为113.2%、103.6%和93.4%。本方法具有灵敏、准确、快速的特点,可用于白藜芦醇苷的药代动力学研究。     

LC／MS^n法鉴定乙氧苯柳胺在家兔体内的主要代谢产物

报道了治疗痤疮新药乙氧苯柳胺〖Ｎ－４－（乙氧苯基）－２－羟基苯甲酰胺〗在家铭记悄中的主要代谢产物。选择４只健康家兔,单剂量口服４００ｍｇ乙氧苯柳胺,收集服药后０～１０ｈ的尿样,将未经或经过β－Ｄ－葡萄糖苷酸酶／硫酸酯酶水解的尿样以固相萑取柱纯化后,采用ＬＣ／ＭＳ＾ｎ方法对尿中推测的代物和标准品分别进行选择离子监测（ＳＩＭ）和多级全扫描质谱（ＭＳ＾ｎ）分析。结果在尿中发现了６个代谢物,分别为利胆酚〖     

LC/MSn法鉴定乙氧苯柳胺在家兔体内的主要代谢产物

报道了治疗痤疮新药乙氧苯柳胺［Ｎ－４－（乙氧苯基）－２－羟基苯甲酸胺］在家兔尿中的主要代谢产物．选择 ４只健康家兔,单剂量口服 ４００ ｍｇ乙氧苯柳胺,收集服药后 ０～１０ ｈ的尿样．将未经或经过β－Ｄ－葡萄糖苷酸酶／硫酸酯酶水解的尿样以固相萃取柱纯化后,采用 ＬＣ／ＭＳ~ｎ方法对尿中推测的代谢物和标准品分别进行选择离子监测（ＳＩＭ）和多级全扫描质谱（ＭＳ~ｎ）分析．结果在尿中发现了 ５个代谢物,分别为利胆酚［Ｎ－（对－羟基苯基）－水杨酰胺］以及利胆酚和乙氧苯柳胺与硫酸或葡糖醛酸的结合物．     

超高压液相色谱-飞行时间质谱法对比分析沙丁胺醇在猪尿液和血浆中的代谢产物

采用高分辨质谱及代谢物鉴定软件,系统分析了猪尿液和血浆中沙丁胺醇代谢产物。样品用乙腈沉淀蛋白,经离心过滤后,采用Agilent Plus C18色谱柱,以乙腈和醋酸溶液(含0.2%醋酸)作为流动相进行梯度洗脱,采用高分辨质谱(UHPLC-QTOF MS)±离子模式进行检测,利用软件Agilent MassHunter MetaboliteID与人工相结合分析检测数据。结果表明,经灌胃给药后猪尿液中鉴定出沙丁胺醇原形药和葡糖醛酸化、苯环羟基化、N-氧化、苯环甲氧基化、羟基化脱水共5个代谢产物,其中2个代谢物未见文献报道;而血浆中仅检测原型药物和2个代谢物,包括沙丁胺醇的葡糖醛酸化和N-氧化产物。     

液相色谱-串联质谱法检测蜂蜜中杀虫脒及其代谢产物残留

建立了液相色谱-串联质谱分析洋槐蜜、荆条蜜、蜂巢蜜、杂花蜜、野蜂蜜中杀虫脒及其代谢产物残留的方法。样品经氢氧化钠水溶液稀释溶解后,采用Waters Oasis HLB固相萃取柱净化。样品提取液经Agilent XDB-C18色谱柱分离,以0.1%甲酸水溶液和乙腈为流动相进行梯度洗脱。以电喷雾正离子(ESI+)模式电离,多反应监测(MRM)模式检测,基质匹配标准溶液外标法定量。杀虫脒及其代谢产物(4-氯邻甲苯胺)在2.5～250 μg/L范围内呈线性相关,相关系数(r)均大于0.999;定量限(S/N＞10)为5 μg/kg,检出限(S/N＞3)为2.5 μg/kg。各种蜂蜜基质样品在5、10和20 μg/kg添加水平时,杀虫脒及其代谢产物的回收率范围分别为75.8%～113.8%和85.6%～114.3%,相对标准偏差(RSD)分别为4.8%～10.2%和4.7%～9.1%,可以满足蜂蜜中杀虫脒及其代谢产物残留量的检测需要。     

New Metabolites of Aconitine in Rabbit Urine

A sensitive analytical method to identify and determine aconitine and its metabolites in rabbit urine was developed by liquid chromatography-electrospray ionization mass spectrometry (LC/ESI-MS^n). In this method,aconitine and its four metabolites in rabbit urine were isolated and deduced as 16-O-demethylaconine (M1), benzoylaconine (M2),16-O-demethylbenzoylaconine (M3) and aconine(M4).M1 and M3 are new metabolites of aconitine and M2 and M4 are first identified in rabbit urine.     

Effect of pH on the Metabolism of Aconitine under Rat Intestinal Bacteria and Analysis of Metabolites Using HPLC/MS-MSn Technique

A semi‐quantitative method of mass spectrometry (MS) has been described for the analysis of metabolites of aconitine by rat intestinal bacteria at different pH. At pH 7.0, the rat intestinal bacteria exhibit optimal activity for the metabolism of aconitine. A high‐performance liquid chromatography‐electrospray ionization multiple‐stage mass spectrometry (HPLC/ESI‐MSⁿ) method has been applied to investigate the characteristic product ions of metabolites. Then, the logical fragmentation pathways of metabolites have been proposed. By comparing the retention time (t_R) of HPLC and the ESI‐MSⁿ data with the data of standard compounds and reports from literature, ten metabolites have been identified and a distinctive metabolite (15‐deoxyaconitine) has been deduced first time. The experimental results demonstrate that HPLC/ESI‐MSⁿ is a specific and useful method for the identification of metabolites of aconitine. Also, in the present paper, the HPLC‐MS method was introduced to determine the synthetical metabolite prior to the study of the toxicity by the method of Bliss.     

Analysis of the Aconitine Alkaloids in Chuanwu by Electrospray Ionization ／ Tandem Mass Spectrometry

An electrospray ionization / tandem mass spectrometric (ESUMS/MS) method was developed for the simultaneous identification and analysis of three aconitine alkaloids [mesacontine (MA), hypaconitine (HA), and aconitine (A)] as intact molecules at low nanogram level in Chinese traditional medicine Chuanwu decoction as well as in human whole blood extract without chromatographic separation.     

Selective determination of total normal microcystin by colorimetry, LC/UV detection and/or LC/MS

Microcystins, hepatotoxic cyclic heptapeptides, are produced by freshwater cyanobacteria, and are classified four groups according to the amino acid structure at unit 7. Normal microcystins contain N-methyldehydroalanine (Mdha) or dehydroalanine (Dha) at unit 7, and command the great part of all microcystins. As unusual microcystin classes, [Dhb⁷]microcystins, [ - and -Ala⁷, or N-MeAla⁷]microcystins and [ -Ser⁷]microcystins have been found.

On tumor initiation and/or promotion activities of microcystins, the tumor promotion activity of normal microcystins has been found, but cancer-related activities of microcystins belonging in the other classes have not been clear.

To determine normal microcystins as hepatotoxic tumor promoters, a selective determination method was developed. Only Mdha or Dha in normal microcystins was reacted with glutathione (GSH). The GSH-normal microcystins conjugates were reacted with trinitrobenzene sulfonate (TNBS). The TNB–GSH-normal microcystin conjugate can be determined as the total normal microcystin by colorimetry. After methanolysis of the conjugate, dimethyl TNB–glutamate from the conjugate was determined by liquid chromatography/ultraviolet detection (LC/UV) and/or liquid chromatography/mass spectrometry (LC/MS). The detection limits of the total normal microcystin by colorimetry, LC/UV and/or LC/MS were 1 μg, 10 and 0.1 ng, respectively.     

Detecting and Identifying in vivo Metabolites of Brodimoprim via LC/ESI-MS with Data-dependent Scanning

The present article covers a simple approach to detect and subsequently identify in vivo metabolites of brodimoprim, using high performance liquid chromatography coupled to ion trap mass spectrometer（LC/ESI-MS）, which is based on a data-dependent acquisition of isotope ions and result verified by full scan mass spectrum. The distinguished advantage of data-dependent scan is rapidness because it requires minimum sample preparation, and all the necessary data can be obtained in one chromatographic run. In addition, it is highly sensitive and selective, allowing detection of trace metabolites even in the presence of complex biomatrix. As a result, four phase-Ⅰ（M1--M4） and four Phase-Ⅱ（M5--M8） metabolites of brodimoprim were identified in urine after the oral administration of hrodimoprim to Wistar rats. Their chemical structures were proposed based on the interpretation of their CID fragmentation characterizations and the metabolic pathway was exhibited in this article.     

A method for determination of dimethyl benzoylphenyl urea (BPU) in human plasma by using LC/UV

Dimethyl benzoylphenyl urea (BPU) inhibited tubulin polymerization, caused microtubule depolymerization in vitro and demonstrated activity against solid tumors. BPU is being tested in phase I clinical trials. A rapid and specific method using LC/UV has been developed for quantitation of BPU in human heparin-containing plasma to perform pharmacokinetic and pharmacodynamic studies. BPU is extracted from plasma into acetonitrile:n-butyl-chloride using paclitaxel as the internal standard and separated on a Waters Symmetry C18 (3.9 x 150 mm, 5 microm) column with acetonitrile-water mobile phase (70:30, v/v) using isocratic flow at 1 mL/min for a run time of 5 min. Ultraviolet detection was utilized and performed at 225 nm for BPU and paclitaxel. The retention times were 1.9 min for paclitaxel and 4.1 min for BPU. Calibration curves were generated over the range of 0.01-10 microg/mL with coefficient of determination of > 0.99. The values for within-day and between-day precision were < or = 17.0% at the LLOQ and < or = 7.4% at the low, medium and high quality controls; accuracy was +/- 5.4%. Following administration of BPU 320 mg as a weekly oral dose to a patient with advanced solid tumor malignancies, the maximum plasma concentration was 2 micro g/mL and concentrations were quantifiable up to 168 h after administration. The lower limit of quantitation of 0.01 microg/mL allows for successful measurement of plasma concentrations in patients.     

Biotransformation of Timosaponin BII into Seven Characteristic Metabolites by the Gut Microbiota

Timosaponin BII is one of the most abundant Anemarrhena saponins and is in a phase II clinical trial for the treatment of dementia. However, the pharmacological activity of timosaponin BII does not match its low bioavailability. In this study, we aimed to determine the effects of gut microbiota on timosaponin BII metabolism. We found that intestinal flora had a strong metabolic effect on timosaponin BII by HPLC-MS/MS. At the same time, seven potential metabolites (M1–M7) produced by rat intestinal flora were identified using HPLC/MS-Q-TOF. Among them, three structures identified are reported in gut microbiota for the first time. A comparison of rat liver homogenate and a rat liver microsome incubation system revealed that the metabolic behavior of timosaponin BII was unique to the gut microbiota system. Finally, a quantitative method for the three representative metabolites was established by HPLC-MS/MS, and the temporal relationship among the metabolites was initially clarified. In summary, it is suggested that the metabolic characteristics of gut microbiota may be an important indicator of the pharmacological activity of timosaponin BII, which can be applied to guide its application and clinical use in the future.     

采用自动前处理LC/MS进行血浆中药物的快速分析

药物研究的发展对高通量的样品处理分析提出了越来越高的要求,减少样品制备时间和分析时间是解决问题的关键。我们新近发展了一种具有在线稀释旁路和新的样品预处理柱的Shim-Pack MAYI-ODS自动柱切换HPLC和LC／MS系统,该系统无需样品前处理,可直接进样进行血浆、血清中的药物分析。本文利用自动样品前处理LC／MS系统,用ODS整体柱实现了血浆中药物的快速分析。包括样品预处理,整个分析仅需1．2min完成。     

气相色谱法分析尿液样品中的阿特拉津及其代谢物

建立了尿液样品中阿特拉津(ATZ)及其代谢物脱乙基阿特拉津(DEA)、脱异丙基阿特拉津(DIA)、脱乙基脱异丙基阿特拉津(DEDIA)的气相色谱分析方法。样品经乙酸乙酯萃取、硫酸钠脱水、弗罗里硅土净化、浓缩后用气相色谱-电子俘获检测器分析。对样品萃取时的pH值等条件进行了优化,获得了较好的回收率。方法的检出限分别为DEDIA 0.0025 mg/L,DEA、DIA、ATZ 0.005 mg/L。4种化合物在进样量为0.2~8 ng时与其峰面积呈良好的线性关系。利用该方法对阿特拉津生产厂工人的尿液样品进行了分析,尿液中4种化合物的质量浓度为：DEDIA 0.003～0.301 mg/L,DEA 0.005～0.011 mg/L,DIA 0.006～0.276 mg/L,ATZ 0.005～0.012 mg/L。     

水产品中喹烯酮和喹赛多及其主要代谢物残留的HPLC-MS/MS检测方法研究

以草鱼、南美白对虾、中华绒鳌蟹为样品,建立了喹烯酮(QCT)和喹赛多(CYA)及其主要代谢物脱二氧喹烯酮(BDQCT)、3-甲基喹啉-2-羧酸(MQCA)、脱二氧喹赛多(BDCYA)和喹啉-2-羧酸(QCA)多残留的高效液相色谱-串联质谱(HPLC-MS/MS)确证检测方法。组织样品经乙腈-乙酸乙酯(1∶1)、盐酸溶液分步提取,Oasis MAX固相萃取柱净化,以甲醇、乙腈和0.1%甲酸溶液为流动相,经Waters XBridge C18色谱柱分离后,采用HPLC-MS/MS仪进行测定。采取正离子选择反应监测模式检测,外标法定量。结果表明,喹烯酮和喹赛多及其主要代谢物的响应值与其质量浓度在2~500μg/L范围内线性关系良好。在加标浓度为5~50μg/kg范围内,6种待测物的平均回收率为76.3%~94.2%,相对标准偏差为4.2%~11.7%。方法的检出限为0.5~1.6μg/kg,定量下限为2.0~5.0μg/kg。该方法适用于水产品中QCT和CYA及其主要代谢物残留的确证检测和同时定量分析。